SCHEMBL8188941

SCHEMBL8188941

C#CCNC(=O)c1c(NC(C)C)nc(C#Cc2ccc(OC)c(OC)c2)n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.39
LMNA P02545 3/20 0.35
MAPT P10636 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
SCD O00767 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
MAPK1 P28482 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8184435 0.92 ACACB (0.40) ACACBLMNAMAPTCDK5CDK5R1
SCHEMBL8184731 0.89 ACACB (0.38) ACACBLMNAALDH1A1SMN1; SMN2TP53
SCHEMBL8180999 0.88 SYK (0.39) ACACBLMNAALDH1A1GAAKDM4E
SCHEMBL8189038 0.88 PGK1 (0.38) ACACBLMNAALDH1A1SMN1; SMN2GAA
SCHEMBL8179729 0.87 ACACB (0.35) ACACBLMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL8195154 0.86 CYP3A4 (0.37) ACACBMAPTALDH1A1TSHRKDM4E
SCHEMBL8184729 0.86 CFTR (0.35) ACACBMAPTALDH1A1TSHRHTT
SCHEMBL8183622 0.86 ACACB (0.37) ACACBLMNAALDH1A1SMN1; SMN2GAA
SCHEMBL8192147 0.86 EGLN1 (0.35) ACACBLMNAALDH1A1SMN1; SMN2GAA
SCHEMBL8179960 0.86 TNF (0.37) ACACBMAPTALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077557-A1 8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE A2A RECEPTOR ANTAGONISTS SCHWARZ PHARMA AG (DE) 2008-07-03 WO disclosed